Hereditary pituitary hyperplasia with infantile gigantism.

CONTEXT We report hereditary pituitary hyperplasia. OBJECTIVE The objective of the study was to describe the results of the clinical and laboratory analysis of this rare instance of hereditary pituitary hyperplasia. DESIGN The study is a retrospective analysis of three cases from one family. SETTING The study was conducted at the National Institutes of Health, a tertiary referral center. PATIENTS A mother and both her sons had very early-onset gigantism associated with high levels of serum GH and prolactin. INTERVENTIONS The condition was treated by total hypophysectomy. MAIN OUTCOME MEASURE(S) We performed clinical, pathological, and molecular evaluations, including evaluation basal and provocative endocrine testing, neuroradiological assessment, and assessment of the pituitary tissue by microscopic evaluation, immunohistochemistry, and electron microscopy. RESULTS All three family members had very early onset of gigantism associated with abnormally high serum levels of GH and prolactin. Serum GHRH levels were not elevated in either of the boys. The clinical, radiographic, surgical, and histological findings indicated mammosomatotroph hyperplasia. The pituitary gland of both boys revealed diffuse mammosomatotroph hyperplasia of the entire pituitary gland without evidence of adenoma. Prolactin and GH were secreted by the same cells within the same secretory granules. Western blot and immunohistochemistry demonstrated expression of GHRH in clusters of cells distributed throughout the hyperplastic pituitary of both boys. CONCLUSIONS This hereditary condition seems to be a result of embryonic pituitary maldevelopment with retention and expansion of the mammosomatotrophs. The findings suggest that it is caused by paracrine or autocrine pituitary GHRH secretion during pituitary development.

[1]  C. Stratakis,et al.  Pituitary tumors in childhood: update of diagnosis, treatment and molecular genetics , 2008, Expert review of neurotherapeutics.

[2]  Thomas Ried,et al.  Spectral karyotyping analysis of human and mouse chromosomes , 2006, Nature Protocols.

[3]  C. Stratakis,et al.  Pituitary pathology in patients with Carney Complex: growth-hormone producing hyperplasia or tumors and their association with other abnormalities , 2006, Pituitary.

[4]  A. Vortmeyer,et al.  Effects of VHL deficiency on endolymphatic duct and sac. , 2005, Cancer research.

[5]  R. Weil,et al.  Common genetic changes in hereditary and sporadic pituitary adenomas detected by comparative genomic hybridization , 2005, Genes, chromosomes & cancer.

[6]  A. Mahapatra,et al.  Pediatric pituitary adenoma: a series of 42 patients , 2005, Journal of Clinical Neuroscience.

[7]  H. Sakano,et al.  Joining Mutants of RAG1 and RAG2 that Demonstrate Impaired Interactions with the Coding-end DNA* , 2004, Journal of Biological Chemistry.

[8]  S. Wientroub,et al.  Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. , 2002, The Journal of clinical endocrinology and metabolism.

[9]  H. Koutselini,et al.  Expression of growth hormone-releasing hormone in human primary endometrial carcinomas. , 2002, European journal of endocrinology.

[10]  R. Shiekhattar,et al.  A core–BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[11]  D. Lüdecke,et al.  Growth hormone-secreting pituitary adenomas in childhood and adolescence: features and results of transnasal surgery. , 1999, Neurosurgery.

[12]  A. Vortmeyer,et al.  Pluripotent tumor cells in benign pituitary adenomas associated with multiple endocrine neoplasia type 1. , 1998, Cancer research.

[13]  J. Dötsch,et al.  Gs alpha mutation at codon 201 in pituitary adenoma causing gigantism in a 6-year-old boy with McCune-Albright syndrome. , 1996, The Journal of clinical endocrinology and metabolism.

[14]  S. Keeney,et al.  Chromosomal localization and cDNA cloning of the genes (DDB1 and DDB2) for the p127 and p48 subunits of a human damage-specific DNA binding protein. , 1995, Genomics.

[15]  J. Barrett,et al.  KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. , 1995, Science.

[16]  P. Chambon,et al.  Cloning of the 62-kilodalton component of basic transcription factor BTF2. , 1992, Science.

[17]  C. Schneider,et al.  Gas2, a growth arrest-specific protein, is a component of the microfilament network system , 1992, The Journal of cell biology.

[18]  S. Lightman,et al.  Growth hormone-releasing hormone transcripts in human pituitary adenomas. , 1992, The Journal of clinical endocrinology and metabolism.

[19]  P. Donohoue,et al.  Pituitary gigantism caused by growth hormone excess from infancy. , 1992, The Journal of pediatrics.

[20]  M. Merino,et al.  Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. , 1991, The New England journal of medicine.

[21]  S. Asa,et al.  Gigantism due to pituitary mammosomatotroph hyperplasia. , 1990, The New England journal of medicine.

[22]  S. Asa,et al.  Pituitary Mammosomatotroph Adenomas Develop in Old Mice Transgenic for Growth Hormone-Releasing Hormone , 1990, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[23]  D. Housman,et al.  Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus , 1990, Cell.

[24]  S. Asa,et al.  Adenohypophysial changes in mice transgenic for human growth hormone-releasing factor: a histological, immunocytochemical, and electron microscopic investigation. , 1989, Endocrinology.

[25]  T. Sano,et al.  Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. , 1988, Endocrine reviews.

[26]  R. Hammer,et al.  Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene. , 1988, Molecular endocrinology.

[27]  W. Halliday,et al.  Human Fetal Adenohypophysis , 1986 .

[28]  J. Wass,et al.  Circulating growth hormone releasing factor concentrations in normal subjects and patients with acromegaly. , 1984, British medical journal.

[29]  B. Scheithauer,et al.  A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor. , 1984, The Journal of clinical endocrinology and metabolism.

[30]  F. V. Schaik,et al.  Sequence of cDNA encoding human insulin-like growth factor I precursor , 1983, Nature.

[31]  F. Bloom,et al.  Immunohistochemical detection of growth hormone-releasing factor in brain , 1983, Nature.

[32]  W. Vale,et al.  Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour , 1982, Nature.

[33]  E. Espiner,et al.  Pituitary gigantism in a 31 month old girl: endocrine studies and successful response to hypophysectomy , 1981, Journal of endocrinological investigation.

[34]  K. Kovacs,et al.  Mammosomatotroph adenoma of the pituitary associated with gigantism and hyperprolactinemia. A morphological study including immunoelectron microscopy , 2004, Acta Neuropathologica.

[35]  E. Müller,et al.  Neuroendocrine control of growth hormone secretion , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[36]  K. Kovacs,et al.  Pituitary hyperplasia. , 2003, Hormones.

[37]  B. Scheithauer,et al.  Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation. , 1993, The Journal of clinical endocrinology and metabolism.

[38]  M. Thorner,et al.  Molecular cloning and expression of a human anterior pituitary receptor for growth hormone-releasing hormone. , 1993, Molecular endocrinology.

[39]  B. Ross,et al.  Morphologic effects of hGRH gene expression on the pituitary, liver, and pancreas of MT-hGRH transgenic mice. An in situ hybridization analysis. , 1992, The American journal of pathology.

[40]  W. Halliday,et al.  Human fetal adenohypophysis. Electron microscopic and ultrastructural immunocytochemical analysis. , 1988, Neuroendocrinology.

[41]  R. Evans,et al.  Gene encoding human growth hormone-releasing factor precursor: structure, sequence, and chromosomal assignment. , 1985, Proceedings of the National Academy of Sciences of the United States of America.